Free Trial
NYSEARCA:PBE

Invesco Biotechnology & Genome ETF (PBE) Price, Holdings, & News

$66.59 -0.08 (-0.12%)
Closing price 07/25/2025 04:10 PM Eastern
Extended Trading
$66.59 0.00 (0.00%)
As of 07/25/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

Key Stats

Today's Range
$66.25
$66.64
50-Day Range
$61.70
$67.31
52-Week Range
$54.52
$72.84
Volume
2,428 shs
Average Volume
7,107 shs
Market Capitalization
$229.74 million
Assets Under Management
$229.72 million
Dividend Yield
0.24%
Net Expense Ratio
0.58%
Aggregate Rating
Moderate Buy

ETF Overview

Invesco Biotechnology & Genome ETF Expenses

TypePBEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.56%0.56%0.51%0.53%
Other Expenses0.08%0.47%0.56%0.59%0.56%
Total Expense0.58%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.58%0.60%0.63%0.58%0.60%
Receive PBE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.

PBE ETF News Headlines

PBE Invesco Biotechnology & Genome ETF
Invesco Dynamic Biotech & Genome ETF (PBE)
Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
See More Headlines

PBE ETF - Frequently Asked Questions

Invesco Biotechnology & Genome ETF's stock was trading at $66.53 at the beginning of 2025. Since then, PBE stock has increased by 0.1% and is now trading at $66.59.

Invesco Biotechnology & Genome ETF's top institutional investors include YHB Investment Advisors Inc. (0.70%), Massachusetts Wealth Management (0.53%), Newman Dignan & Sheerar Inc. (0.30%) and Janney Montgomery Scott LLC (0.15%).

Shares of PBE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Invesco Biotechnology & Genome ETF investors own include Micron Technology (MU), Pfizer (PFE), Devon Energy (DVN), Intel (INTC), Activision Blizzard (ATVI), NVIDIA (NVDA) and Bristol Myers Squibb (BMY).

Fund Details

Issuer
Invesco
Fund Name
Invesco Biotechnology & Genome ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:PBE
Inception Date
6/23/2005
Fund Manager
Peter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser

Fund Focus

Asset Class
Equity
Benchmark
Dynamic Biotech & Genome Intellidex Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
32

Fund Statistics

Assets Under Management
$229.72 million
Average Daily Volume
$5.53 thousand
Discount/Premium
0.01%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Invesco Capital Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Invesco Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
Optionable
Options Volume
1
Put Options
5
Call Options
1
Short Interest
2,500 shs

Miscellaneous

Beta
0.87
Creation Unit
10,000
Creation Fee
$500.00
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Top 10 PBE Holdings

PBE Sector Exposure

PBE Industry Exposure


This page (NYSEARCA:PBE) was last updated on 7/28/2025 by MarketBeat.com Staff
From Our Partners